TLX receives ethics approval to commence Glioblastoma Study
Filed with ASX · · 2 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Half Yearly Report and Accounts
- Telix files Ph III trial for Kidney Cancer Imaging in Europe
- Collaboration on Renal Cancer Imaging for Japanese market
- Telix JV Entity Extends Contract with Endocyte to Include EU
- Telix receives $55m Overseas Finding
Later from Telix Pharmaceuticals
- Telix completes acquisition of Atlab Pharma
- Strategic Collaboration Agreement with GenesisCare
- Cyclotek Manufacturing Partnership for Kidney Cancer Imaging
- Telix and ANMI Expand PSMA Imaging Partnership
- Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals